Production and Quality Requirements of Human Platelet Lysate: A Position Statement from the Working Party on Cellular Therapies of the International Society of Blood Transfusion
Abstract
Human platelet lysate (HPL) is an effective novel growth medium supplement for xenofree ex vivo propagation of human cells for cell therapy and regenerative medicine. Consensus is needed to ensure the quality and safety of HPL supplements regarding the source of platelet concentrates, donor variability, manufacturing processes, and minimum release criteria. It is critical to guarantee HPL pathogen safety by implementing measures including...
Paper Details
Title
Production and Quality Requirements of Human Platelet Lysate: A Position Statement from the Working Party on Cellular Therapies of the International Society of Blood Transfusion
Published Date
Jan 1, 2020
Journal
Volume
38
Issue
1
Pages
13 - 23
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History